Larry C. Heaton II is CEO at Zomedica Corp. (ZOM). They have made 7 open-market trades across 2 companies since 2023, most recently 2026-05-08.
CIK 0001213207
7 open-market purchases totalling $132K since 2023, never a sale. Across 6 scored buys the stock is down 6.3% at ninety days, and 11.9 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| TSSI | 1,250,000 | $8.8M |
| ZOM | 628,855 | $61K |
| Total | $8.9M |
Shares reported on the most recent Form 4, priced at the 2026-05-08 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 67% | 33% |
| Avg Move | +2.3% | +3.9% | -6.3% |
| Alpha | +1.2% | +1.3% | -11.9% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TSSI | BUY | 2026-05-08 | 2026-05-08 | $0.11 | $28K | -10.1% | +7.4% | -13.3% |
| ZOM | BUY | 2025-03-17 | 2025-03-18 | $0.06 | $30K | N/A | N/A | N/A |
| ZOM | BUY | 2024-11-11 | 2024-11-12 | $0.12 | $12K | -7.5% | -12.1% | -13.9% |
| ZOM | BUY | 2024-09-05 | 2024-09-05 | $0.13 | $13K | +3.0% | +3.6% | +1.6% |
| ZOM | BUY | 2024-05-13 | 2024-05-13 | $0.14 | $14K | +25.8% | +8.0% | +6.6% |
| ZOM | BUY | 2023-11-17 | 2023-11-17 | $0.17 | $17K | +1.7% | +16.8% | -15.9% |
| ZOM | BUY | 2023-05-26 | 2023-05-26 | $0.19 | $19K | +1.1% | -0.6% | -3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.